DrugOct 23, 2024
Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial recall — FDA D-0010-2025
Failed Impurities/Degradation Specifications.
Class IIFDA: TerminatedACCORD HEALTHCARE, INC.
Recall records from October 2024
These records include useful source details for the selected month.
DrugOct 23, 2024
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle recall — FDA D-0012-2025
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
Class IFDA: TerminatedBionpharma Inc.
DrugOct 23, 2024
First Aid Antiseptic Ointment, Povidone Iodine USP 10%, Inactive Ingredients: mineral oil recall — FDA D-0013-2025
Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product…
Class IIFDA: OngoingZhejiang Jingwei Pharmaceutical Co., Ltd.
DrugOct 16, 2024
123Herbals Vail-Bon Jie Yang Wan capsules, 30-count bottle, Vall Boon Medical Factory Sdn recall — FDA D-0008-2025
Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared dexamethasone and chlorpheniramine.
Class IFDA: Ongoing123Herbals
VehicleOct 15, 2024
BMW structure recall — NHTSA campaign 24V764000
BMW of North America, LLC (BMW) is recalling certain 2018-2022 X3 sDrive30i, X3 xDrive30i, X3 M40i, and X3 M vehicles. The attachment for the rear cargo rail may become damaged in a rear…
structureBMW of North America, LLC
DrugOct 9, 2024
Supercore Products Group Hard Steel Capsules recall — FDA D-0003-2025
Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.
Class IFDA: OngoingSupercore Products Group Inc.
DrugOct 9, 2024
Ryaltris recall — FDA D-0006-2025
Defective Delivery System: The dip tube is clogged causing the spray not to work.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugOct 9, 2024
Glenmark Pharmaceuticals Inc., USA Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for recall — FDA D-0002-2025
Defective Container: Firm received complaints of broken tube at the seal.
Class IIIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugOct 9, 2024
Atorvastatin Calcium Tablets, USP, 40mg recall — FDA D-0001-2025
Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
Class IIFDA: TerminatedNivagen Pharmaceuticals Inc
DrugOct 9, 2024
Supercore Products Group Gold Hard Steel Plus Liquid, 2 FL OZ bottles, UPC 787188873199 recall — FDA D-0004-2025
Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.
Class IFDA: OngoingSupercore Products Group Inc.
VehicleOct 3, 2024
Honda steering recall — NHTSA campaign 24V744000
Honda (American Honda Motor Co.) is recalling certain 2023-2025 Acura Integra, Civic Type R, CR-V Hybrid, CR-V, HR-V, 2022-2025 Civic, Civic Hatchback, 2024-2025 Acura Integra Type S, 2025…
steeringHonda (American Honda Motor Co.)
DrugOct 2, 2024
AbbVie Refresh LACRI-LUBE recall — FDA D-0665-2024
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Class IIFDA: OngoingAbbVie Inc.
DrugOct 2, 2024
SHEET SPF 30 MINERAL Vivier Sheer SPF 30 Mineral With Antioxidants recall — FDA D-0662-2024
Microbial Contamination of Non-Sterile Product
Class IIFDA: OngoingVivier Pharma, Inc.
DrugOct 2, 2024
Guru Infla-650 Herbal Dietary Supplement, 700mg recall — FDA D-0666-2024
Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.
Class IIFDA: OngoingGuru Inc.
DrugOct 2, 2024
AbbVie Refresh P.M recall — FDA D-0664-2024
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Class IIFDA: OngoingAbbVie Inc.
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.